FLR
56
-4
HOG
33
-2
AMGN
38
5
LUV
42
3
APA
39
-2
KMX
52
2
CPB
32
-3
COF
54
-3
MPC
28
-5
ESS
59
5
MHK
53
-2
HPE
46
-5
MAT
43
-6
ABT
62
2
IP
59
5
EXPD
40
-2
PX
55
-5
WAT
37
-3
T
53
9
ROK
51
-3
FLR
56
-4
HOG
33
-2
AMGN
38
5
LUV
42
3
APA
39
-2
KMX
52
2
CPB
32
-3
COF
54
-3
MPC
28
-5
ESS
59
5
MHK
53
-2
HPE
46
-5
MAT
43
-6
ABT
62
2
IP
59
5
EXPD
40
-2
PX
55
-5
WAT
37
-3
T
53
9
ROK
51
-3
Financhill
Back

ProQR Therapeutics NV Quote, Financials, Valuation and Earnings

Gold Set to Skyrocket as Fed Slashes Rates

Click here for the details on this incredible opportunity.
Sell
42

PRQR
ProQR Therapeutics NV

Last Price:
3.50
Seasonality Move:
32.86%

7 Day Trial

ALL ACCESS PASS

$ 7

AI DIVIDENDS: No. 1 Way to Collect Passive Income

Click here to get it for free.

ProQR Therapeutics NV Price Quote

$3.50
+0.01 (+0.29%)
(Updated: October 24, 2024 at 6:55 PM ET)

ProQR Therapeutics NV Key Stats

Sell
42
ProQR Therapeutics NV (PRQR) is a Sell
Day range:
$3.16 - $3.83
52-week range:
$1.11 - $4.62
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
18.47
P/B ratio:
8.77%
Volume:
5.1M
Avg. volume:
2.4M
1-year change:
183.74%
Market cap:
$308.8M
Revenue:
$7.1M
EPS:
$-0.28

How Much Does ProQR Therapeutics NV Make?

Is ProQR Therapeutics NV Growing As A Company?

  • What Is ProQR Therapeutics NV's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 4.17%
  • What Is ProQR Therapeutics NV's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

ProQR Therapeutics NV Stock Price Performance

What Is ProQR Therapeutics NV 52-Week High & Low?

ProQR Therapeutics NV Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ProQR Therapeutics NV?

Is ProQR Therapeutics NV Cash Flow Positive?

  • What Is PRQR Cash Flow From Operations?
    Cash flow from operations (TTM) is -$37.2M
  • What Is ProQR Therapeutics NV’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$2.2M
  • What Is ProQR Therapeutics NV’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$14.3M

ProQR Therapeutics NV Return On Invested Capital

  • Is Management Doing A Good Job?
    PRQR return on invested capital is -46.6%
  • What Is ProQR Therapeutics NV Return On Assets?
    ROA measures how assets are converting to revenues and is -16.12%
  • What Is PRQR Return On Equity?
    ROE is a measure of profitability and is -52.19%

ProQR Therapeutics NV Earnings Date & Stock Price

ProQR Therapeutics NV Competitors

ProQR Therapeutics NV Dividend Yield

ProQR Therapeutics NV Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 77.28%
Revenue: 416.67% -36.83%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 4.13
Upside from Last Price: 18.34%

Major Shareholders

  • How many PRQR shares are owned by institutional investors?
    27.1M PRQR shares are owned by institutional investors
  • How many PRQR shares are owned by insiders?
    74.5M PRQR shares are owned by insiders